✦ LIBER ✦

Inhibition of T cell responses by activated CD8+ T cells is mediated by IFN-γ and is defective in chronic progressive multiple sclerosis

✍ Scribed by K.E. Balashov; S.J. Khoury; H.L. Weiner

Book ID: 119108892
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 148 KB
Volume: 54
Category: Article
ISSN: 0165-5728
DOI: 10.1016/0165-5728(94)90257-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

IL-18 is linked to raised IFN-γ in multi

IL-18 is linked to raised IFN-γ in multiple sclerosis and is induced by activated CD4+ T cells via CD40–CD40 ligand interactions

✍ Arnon Karni; Djordje N Koldzic; Padmanabhan Bharanidharan; Samia J Khoury; Howar 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 219 KB

Bystander CD8 T-Cell-Mediated Demyelinat

Bystander CD8 T-Cell-Mediated Demyelination is Interferon-γ-Dependent in a Coronavirus Model of Multiple Sclerosis

✍ Ajai A. Dandekar; Daniela Anghelina; Stanley Perlman 📂 Article 📅 2004 🏛 American Society for Investigative Pathology 🌐 English ⚖ 486 KB

Cyclophosphamide modulates CD4+ T cells

Cyclophosphamide modulates CD4+ T cells into a T helper type 2 phenotype and reverses increased IFN-γ production of CD8+ T cells in secondary progressive multiple sclerosis

✍ Arnon Karni; Konstantin Balashov; Wayne W. Hancock; Padmanabhan Bharanidharan; M 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 505 KB

CD4+ T Cell–Mediated Tumor Rejection Inv

CD4+ T Cell–Mediated Tumor Rejection Involves Inhibition of Angiogenesis that Is Dependent on IFNγ Receptor Expression by Nonhematopoietic Cells

✍ Zhihai Qin; Thomas Blankenstein 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 384 KB

Regression of engineered myeloma cells s

Regression of engineered myeloma cells secreting interferon-γ-inducing factor is mediated by both CD4+/CD8+ T and natural killer cells

✍ Jim Xiang; Zhuang Chen; Hui Huang; Terence Moyana 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Cure of established GL261 mouse gliomas

Cure of established GL261 mouse gliomas after combined immunotherapy with GM-CSF and IFNγ is mediated by both CD8+ and CD4+ T-cells

✍ Karin Enell Smith; Sara Fritzell; Wiaam Badn; Sofia Eberstål; Shorena Janelidze; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 316 KB

## Abstract We were the first to demonstrate that combined immunotherapy with GM‐CSF producing GL261 cells and recombinant IFNγ of preestablished GL261 gliomas could cure 90% of immunized mice. To extend these findings and to uncover the underlying mechanisms, the ensuing experiments were undertake